As it can be inferred, THCs are identified by the expression of hematopoietic markers, including CD14, CD45 and CD163, provided by the myeloid partner, as well as common cancer-related markers (e.g. cytokeratin or EpCAM). The gene discussed is CD163; the disease is cancer.